Q1 2022 Protalix Biotherapeutics Inc Earnings Call Transcript

May 16, 2022 / 12:30PM GMT
Operator

Good morning, ladies and gentlemen, and welcome to the Protalix First Quarter 2022 Financial and Business Results Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I will now turn the conference over to your host, Alexandra Schuman of LifeSci Advisors, Investor Relations for Protalix. You may begin your conference.

Alexandra Schuman;LifeSci Advisors -

Thank you, operator, and welcome to the Protalix BioTherapeutics First Quarter 2022 Financial Results and Business Update Conference Call. With me today are Dror Bashan, President and CEO of Protalix; and Eyal Rubin, Senior Vice President and Chief Financial Officer.

A press release announcing the results and the update was issued this morning and is available now on the Protalix website.

Please take a moment to read the disclaimer about forward-looking statements in the press release. The earnings release and this teleconference include forward-looking statements. These forward-looking statements are subject to known and unknown

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot